<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(1)</volume><submitter>Soffer A</submitter><pubmed_abstract>MolOptimizer is a user-friendly computational toolkit designed to streamline the hit-to-lead optimization process in drug discovery. MolOptimizer extracts features and trains machine learning models using a user-provided, labeled, and small-molecule dataset to accurately predict the binding values of new small molecules that share similar scaffolds with the target in focus. Hosted on the Azure web-based server, MolOptimizer emerges as a vital resource, accelerating the discovery and development of novel drug candidates with improved binding properties.</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>276</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10780997</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MolOptimizer: A Molecular Optimization Toolkit for Fragment-Based Drug Design.</pubmed_title><pmcid>PMC10780997</pmcid><pubmed_authors>Akabayov B</pubmed_authors><pubmed_authors>Rozenberg N</pubmed_authors><pubmed_authors>Soffer A</pubmed_authors><pubmed_authors>Peled A</pubmed_authors><pubmed_authors>Piro D</pubmed_authors><pubmed_authors>Alon S</pubmed_authors><pubmed_authors>Vilenchik D</pubmed_authors><pubmed_authors>Viswas SJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>MolOptimizer: A Molecular Optimization Toolkit for Fragment-Based Drug Design.</name><description>MolOptimizer is a user-friendly computational toolkit designed to streamline the hit-to-lead optimization process in drug discovery. MolOptimizer extracts features and trains machine learning models using a user-provided, labeled, and small-molecule dataset to accurately predict the binding values of new small molecules that share similar scaffolds with the target in focus. Hosted on the Azure web-based server, MolOptimizer emerges as a vital resource, accelerating the discovery and development of novel drug candidates with improved binding properties.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-04T13:59:55.639Z</modification><creation>2025-04-04T13:59:55.639Z</creation></dates><accession>S-EPMC10780997</accession><cross_references><pubmed>38202859</pubmed><doi>10.3390/molecules29010276</doi></cross_references></HashMap>